Pancreatic Cancer Action Network

This Spotlight reviews new pancreatic cancer statistics, federal research funding, key ASCO GI insights, and priorities for accelerating patient progress in 2026.

Each year, the PanCAN Scientific Summit brings together some of the brightest minds in pancreatic cancer research.

Artificial intelligence (AI) is revolutionizing the way cancer is studied and treated.

Pancreatic cancer remains one of the deadliest cancers because it is often detected at an advanced stage when treatment options are limited.

Pancreatic cancer is one of the most challenging cancers to treat.

This month’s Research Spotlight highlights significant advancements in pancreatic cancer research and patient support.

The recent American Cancer Society’s Cancer Statistics, 2025 report was released revealing a sobering trend for pancreatic cancer.

Adaptive Clinical Trial Design Is More Cost Effective, Patient-Centric and Allows for Faster Learning Than Standard Trials

The Pancreatic Cancer Action Network offers webinars, where listeners can learn about various topics from the comfort of their homes.